LYSOGENE Organization
Lysogene is a pioneer in the basic research and clinical development of gene therapy for neurodegenerative disorders.
Headquarters:
Neuilly-sur-seine, Ile-de-France, France
Funding Status:
IPO
Founded Date:
2009
Investor Type:
Healthcare Company
Industry:
Gene Therapies (disease treatment)
Estimated Revenue:
$1M to $10M
Technology:
Others